InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Familial Chylomicronemia SyndromeMultifactorial Chylomicronemia Syndrome
Interventions
OTHER

observational : questionnaries for assessment of health burden

The French IN-FOCUS study was designed to capture current and retrospective data in FCS or MCS. Patients were called by the participating centers and were proposed to answer a paper questionnaire or to connect to a web-based questionnaire The questionnaire was divided into sections specifically assessing various domains of their experience: demographic data, signs, symptoms and complications of the disease, healthcare circuit, management, relationship with healthcare providers, and burden of the disease on daily life. (Details are available as supplementary material S1). The questionnaire focused on symptoms because the interest of quality of life assessment tools is debated in rare diseases with episodic manifestations. Indeed, most of these tools refer to a limited recall period.

Trial Locations (1)

94 100

new French society of atherosclerosis, Saint-Maur-des-Fossés

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Akcea Therapeutics

INDUSTRY

lead

New French Society of Atherosclerosis

OTHER

NCT04223908 - InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia | Biotech Hunter | Biotech Hunter